"The Heart Institute at Largo is now HCA Florida Heart Institute - Largo. Our cardiologists offer many programs, services and interventions to treat cardiovascular disease, from cholesterol testing to our coumadin clinic. We have highly-trained specialists and medical staff covering a full spectrum of cardiovascular medicine that includes cutting edge technologies, advanced research and the development of preventive and educational services. HCA Florida Heart Institute has established itself as a Center of Excellence by the American College of Cardiology for the care and treatment of cardiovascular disease."

During the past decade, The Heart Institute at Largo conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "The Heart Institute at Largo" are "Cardiovascular Disease" (2 trials), "Heart Failure" (1 trials), "Paroxysmal Atrial Fibrillation" (1 trials) and "Ventricular Arrhythmia" (1 trials). Many other conditions were trialed in "The Heart Institute at Largo" in a lesser frequency.

Most popular intervention types in "The Heart Institute at Largo" are "Drug" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "bococizumab (PF-04950615)" (2 trials), "BMS-919373" (1 trials), "Eleclazine" (1 trials) and "Placebo (Matching with BMS-919373)" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Heart Institute at Largo" are 5 trials for "All" genders.

Currently, there are NaN active trials in "The Heart Institute at Largo". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in The Heart Institute at Largo, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in The Heart Institute at Largo, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".